CN Patent

CN103690516A — 一种阿立哌唑口腔膜剂及其制备方法

Assigned to Chongqing Pharmaceutical Research Institute Co Ltd · Expires 2014-04-02 · 12y expired

What this patent protects

本发明涉及一种阿立哌唑口腔膜剂及其制备方法，该膜剂主要由阿立哌唑1-30%、普鲁兰多糖30-80%和添加剂组成。该膜剂崩解快、溶出快，5分钟时累积溶出度达85%以上，10分钟内完全溶出。该膜剂用于治疗精神分裂症，起效迅速，无需咀嚼也无需水送服，有助于改善精神类疾病患者的顺应性。

USPTO Abstract

本发明涉及一种阿立哌唑口腔膜剂及其制备方法，该膜剂主要由阿立哌唑1-30%、普鲁兰多糖30-80%和添加剂组成。该膜剂崩解快、溶出快，5分钟时累积溶出度达85%以上，10分钟内完全溶出。该膜剂用于治疗精神分裂症，起效迅速，无需咀嚼也无需水送服，有助于改善精神类疾病患者的顺应性。

Drugs covered by this patent

Patent Metadata

Patent number
CN103690516A
Jurisdiction
CN
Classification
—
Expires
2014-04-02
Drug substance claim
No
Drug product claim
No
Assignee
Chongqing Pharmaceutical Research Institute Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.